Qalsody Targets Mutation in Rare, Inherited ALS

WEDNESDAY, April 26, 2023 -- The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS). The medication, Qalsody (tofersen), targets a mutation in the...